Theriva Biologics (TOVX) Change in Receivables (2010 - 2012)
Theriva Biologics (TOVX) posted quarterly Change in Receivables of -$19000.0 for Q3 2012, down 116.38% year-over-year from $116000.0 in Q4 2011, and up 50.0% quarter-over-quarter from -$38000.0 in Q2 2012.
Theriva Biologics (TOVX) Change in Receivables (2010 - 2012) Analysis & Trends
Theriva Biologics (TOVX) has reported Change in Receivables for 3 consecutive years, with -$19000.0 the latest figure, recorded in Q3 2012.
- In Q3 2012, Change in Receivables fell 116.38% year-over-year to -$19000.0; the TTM figure through Jun 2013 stood at -$19000.0 (down 110.0% YoY), while the FY2012 annual figure was -$14000.0, down 102.92% from the prior year.
- Change in Receivables grew to -$19000.0 in Q3 2012 per TOVX's latest filing, from -$38000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $453651.0 in Q3 2010 and bottomed at -$169225.0 in Q4 2010.
- Historically, Change in Receivables has averaged $83380.7 across 3 years, with a median of $69000.0 in 2011.
- Annual changes were most pronounced in 2011 — Change in Receivables surged 140.77% — and 2012, when it sank 120.65%.
- Theriva Biologics' Change in Receivables stood at -$169225.0 in 2010, then soared by 140.77% to $69000.0 in 2011, then sank by 127.54% to -$19000.0 in 2012.
- Business Quant data shows TOVX's Change in Receivables at -$19000.0 in Q3 2012, -$38000.0 in Q2 2012, and $43000.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -19,000.00 |
| Sep 30, 2012 | -19,000.00 |
| Jun 30, 2012 | -38,000.00 |
| Jun 30, 2012 | -38,000.00 |
| Mar 31, 2012 | 43,000.00 |
| Mar 31, 2012 | 43,000.00 |
| Dec 31, 2011 | 69,000.00 |
| Dec 31, 2011 | 69,000.00 |
| Sep 30, 2011 | 116,000.00 |
| Sep 30, 2011 | 116,000.00 |
| Jun 30, 2011 | 184,000.00 |
| Jun 30, 2011 | 184,000.00 |
| Mar 31, 2011 | 111,000.00 |
| Mar 31, 2011 | 111,000.00 |
| Dec 31, 2010 | -169,225.00 |
| Dec 31, 2010 | -169,225.00 |
| Sep 30, 2010 | 453,651.00 |
| Sep 30, 2010 | 453,651.00 |